Related references
Note: Only part of the references are listed.Effects of triclosan on host response and microbial biomarkers during experimental gingivitis
Brooke A. Pancer et al.
JOURNAL OF CLINICAL PERIODONTOLOGY (2016)
Cryptococcus neoformans-Induced Macrophage Lysosome Damage Crucially Contributes to Fungal Virulence
Michael J. Davis et al.
JOURNAL OF IMMUNOLOGY (2015)
The fungal pathogen Cryptococcus neoformans manipulates macrophage phagosome maturation
Leanne M. Smith et al.
CELLULAR MICROBIOLOGY (2015)
The Intracellular Life of Cryptococcus neoformans
Carolina Coelho et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 9 (2014)
Triclosan Promotes Staphylococcus aureus Nasal Colonization
Adnan K. Syed et al.
MBIO (2014)
PyElph - a software tool for gel images analysis and phylogenetics
Ana Brandusa Pavel et al.
BMC BIOINFORMATICS (2012)
Triclosan Antagonizes Fluconazole Activity against Candida albicans
J. Higgins et al.
JOURNAL OF DENTAL RESEARCH (2012)
Triclosan impairs excitation-contraction coupling and Ca2+ dynamics in striated muscle
Gennady Cherednichenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
In Vitro Interaction between Fluconazole and Triclosan against Clinical Isolates of Fluconazole-Resistant Candida albicans Determined by Different Methods
Lu Yu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Proteinase, phospholipase, biofilm forming abilities and antifungal susceptibilities of Malaysian Candida isolates from blood cultures
Sun Tee Tay et al.
MEDICAL MYCOLOGY (2011)
Deletion of Cryptococcus neoformans AIF Ortholog Promotes Chromosome Aneuploidy and Fluconazole-Resistance in a Metacaspase-Independent Manner
Camile P. Semighini et al.
PLOS PATHOGENS (2011)
An A643T Mutation in the Transcription Factor Upc2p Causes Constitutive ERG11 Upregulation and Increased Fluconazole Resistance in Candida albicans
Clemens J. Heilmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
John R. Perfect et al.
CLINICAL INFECTIOUS DISEASES (2010)
Occurrence, Efficacy, Metabolism, and Toxicity of Triclosan
JIA-LONG Fang et al.
JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-ENVIRONMENTAL CARCINOGENESIS & ECOTOXICOLOGY REVIEWS (2010)
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS
Benjamin J. Park et al.
AIDS (2009)
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Fungal apoptosis: function, genes and gene function
Amir Sharon et al.
FEMS MICROBIOLOGY REVIEWS (2009)
Programmed cell death in pathogenic fungi
Mark Ramsdale
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2008)
Capsular polysaccharides galactoxylomannan and glucuronoxylomannan from Cryptococcus neoformans induce macrophage apoptosis mediated by Fas ligand
Suellen N. Villena et al.
CELLULAR MICROBIOLOGY (2008)
In vitro biologic activities of the antimicrobials triclocarban, its analogs, and triclosan in bioassay screens:: Receptor-based bioassay screens
Ki Chang Ahn et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2008)
Cryptococcus neoformans glucuronoxylomannan induces macrophage apoptosis mediated by nitric oxide in a caspase-independent pathway
Laura S. Chiapello et al.
INTERNATIONAL IMMUNOLOGY (2008)
Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery: a prospective, double-blinded, randomized controlled trial
Curtis J. Rozzelle et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2008)
Bacterial and H2O2 stress-induced apoptosis-like events in Cryptococcus neoformans
Reiko Ikeda et al.
RESEARCH IN MICROBIOLOGY (2008)
Differential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology
Joseph Meletiadis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Why yeast cells can undergo apoptosis:: death in times of peace, love, and war
Sabrina Buettner et al.
JOURNAL OF CELL BIOLOGY (2006)
Determination of molecular types and genetic heterogeneity of Cryptococcus neoformans and C-gattii in Malaysia
S. T. Tay et al.
MEDICAL MYCOLOGY (2006)
Pharmacokinetics of triclosan following oral ingestion in humans
Gunilla Sandborgh-Englund et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2006)
Treatment of solid organ transplant patients with invasive fungal infections:: should a combination of antifungal drugs be used?
Patricia Munoz et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2006)
Cryptococcus neoformans capsular polysaccharide component galactoxylomannan induces apoptosis of human T-cells through activation of caspase-8
E Pericolini et al.
CELLULAR MICROBIOLOGY (2006)
Increased expression and hotspot mutations of the multidrug efflux transporter, CDR1 in azole-resistant Candida albicans isolates from vaginitis patients
CY Looi et al.
FEMS MICROBIOLOGY LETTERS (2005)
The isolation, characterization and antifungal susceptibilities of Cryptococcus neoformans from bird excreta in Klang Valley, Malaysia
ST Tay et al.
MYCOPATHOLOGIA (2005)
Combination treatment of invasive fungal infections
PK Mukherjee et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Triclosan-bacteria interactions: single or multiple target sites?
MG Escalada et al.
LETTERS IN APPLIED MICROBIOLOGY (2005)
Determination of fungicidal activities against yeasts and molds: Lessons learned from bactericidal testing and the need for standardization
MA Pfaller et al.
CLINICAL MICROBIOLOGY REVIEWS (2004)
Apoptosis induction by glucuronoxylomannan of Cryptococcus neoformans
LS Chiapello et al.
MEDICAL MYCOLOGY (2003)
Fluconazole plus amphotericin B combinations are not contraindicated and may add benefit for the treatment of candidemia
FC Odds
CLINICAL INFECTIOUS DISEASES (2003)
Triclosan as a systemic antibacterial agent in a mouse model of acute bacterial challenge
S Sharma et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate
L Rodero et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformans
T Yamazumi et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Membranotropic effects of the antibacterial agent triclosan
J Villalaín et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2001)
In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices
SM Tambe et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Serologic evidence for Cryptococcus neoformans infection in early childhood
DL Goldman et al.
PEDIATRICS (2001)
Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I
ML Coleman et al.
NATURE CELL BIOLOGY (2001)
Percutaneous penetration and dermal metabolism of triclosan (2,4,4′-trichloro-2′-hydroxydiphenyl ether)
T Moss et al.
FOOD AND CHEMICAL TOXICOLOGY (2000)
Share Paper
